FDA 483 - Acella Pharmaceuticals, LLC - September 17, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Acella Pharmaceuticals, LLC in Alpharetta, GA, revealed significant deficiencies across its quality management system. The firm failed to ensure proper quality control unit responsibilities, thoroughly investigate product discrepancies, adhere to complaint handling procedures, ensure qualified personnel, and follow written production and process control procedures. These issues led to the release of out-of-specification products and a systemic breakdown in quality assurance.
ID · b7225615-5386-4ced-8ce5-2efa60c37d5e